[Indications for immunosuppressive agents in glomerular nephropathies].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D019867:Anti-Glomerular Basement Membrane Disease / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000188:drug therapy; D007678:Kidney Glomerulus; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D011693:Purpura / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D001379:Azathioprine
Indications des immunosuppresseurs dans les néphropathies glomérulaires